Something new is coming to cardiac research.
For decades, researchers have relied on Langendorff systems to advance our understanding of cardiac physiology. As research continues to evolve, so do the expectations for the tools that support it.
We are now giving researchers a first look at the newest addition to the DMT portfolio.
The DMT Langendorff System is being developed as an integrated platform for retrograde aortic perfusion of isolated small-mammalian hearts, supporting controlled experimental conditions and configurable cardiac measurements.
Over the coming weeks, we will reveal more about the system, its capabilities and the research applications it is designed to support.